Featured Research

from universities, journals, and other organizations

Simple Two-in-one Test Signals High Risk After A Heart Attack

Date:
December 5, 2007
Source:
American College of Cardiology
Summary:
Everyone loves a two-fer, but a two-in-one heart test that has the potential to save lives is the real deal. According to new research, pairing two findings from one simple test makes it significantly more likely that doctors will identify patients who face the greatest risk after a heart attack. Problems in both the nervous system and the heart's electrical system spell trouble.

Everyone loves a two-fer, but a two-in-one heart test that has the potential to save lives is the real deal. According to new research, pairing two findings from one simple test makes it significantly more likely that doctors will identify patients who face the greatest risk after a heart attack.

Related Articles


The research found that by examining both the nervous system and the heart's electrical system, cardiologists could better identify which patients were at highest risk of cardiac arrest or death, even years after a heart attack.

"This is important because past studies, focusing on a single test, failed to identify most people at risk," said Derek V. Exner, M.D., M.P.H., a heart rhythm specialist and an associate professor at the University of Calgary's Libin Cardiovascular Institute of Alberta, in Canada. "We developed a simple method of identifying approximately twice as many people at risk. That means we can potentially save more lives."

The REFINE study--formally named the Risk Estimation Following Infarction, Noninvasive Evaluation--assessed two factors critical to the development of serious cardiac arrhythmias. An electrical system that has been damaged by a heart attack sets the stage for serious disturbances in the heart's rhythm. At the same time, a nervous system that's on high alert, even without a patient realizing it, makes it more likely that a serious arrhythmia will take hold and progress to cardiac arrest and death.

For the study, Dr. Exner and his colleagues enrolled 322 patients who had suffered a heart attack and had at least a mild abnormality in the heart's pumping ability. Within 2 to 4 weeks of the heart attack, and again at 10 to 14 weeks, they performed a variety of tests to measure the status of both the nervous system and the heart's electrical system. They then tracked patients for an average of nearly four years.

Having patients wear a heart monitor for 18 to 24 hours as they went about their daily activities turned out to be both a simple and effective way to identify high-risk patients. Using the all-day electrocardiogram, researchers analyzed the heart's electrical system by looking for T-wave alternans (TWA), an abnormality in the heart's rhythm so subtle it must be detected by a computer. Researchers also analyzed the electrocardiogram for evidence that the nervous system was on high alert by looking for abnormalities in "heart rate turbulence" (HRT), a measure of the heart's ability to adapt to change.

Early after a heart attack, TWA and impaired HRT were not accurate warning signs of future risk. At the 10- to 14-week mark, however, TWA and impaired HRT clearly identified patients at increased risk--and they were particularly powerful when used in combination. The 20 percent of patients who had both TWA and impaired HRT on the all-day heart monitor and, in addition, had a persistent abnormality in the heart's pumping ability, faced more than six times the risk of cardiac arrest or death during follow-up when compared to other patients in the study.

Using an exercise test to detect TWA was also effective, but not as simple and efficient as using the all-day heart monitor to look for both impaired HRT and TWA at the same time.

Studies that are expected to begin in 2008 will evaluate whether an implantable cardioverter-defibrillator (ICD) can save the lives of patients with abnormalities in both the nervous system and the heart's electrical system. Until then, those at highest risk should receive intensive follow-up, Dr. Exner said.

"The outlook is good for most heart attack survivors. However, the one in five patients in our study who had abnormal tests were at high risk of serious problems," he said. "Close follow-up with a physician and the use of medications known to be beneficial after a heart attack--aspirin, beta blockers, ACE inhibitors, and statins--are very strongly recommended."

The research appears in the December 11, 2007 issue of the Journal of the American College of Cardiology.

The REFINE study was supported by the Alberta Heritage Foundation for Medical Research, the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Alberta. Cambridge Heart Inc. and GE Healthcare Technologies provided unrestricted donations of equipment and testing materials for the study. Dr. Exner reports having received honoraria and conducted research with GE Healthcare and Cambridge Heart.


Story Source:

The above story is based on materials provided by American College of Cardiology. Note: Materials may be edited for content and length.


Cite This Page:

American College of Cardiology. "Simple Two-in-one Test Signals High Risk After A Heart Attack." ScienceDaily. ScienceDaily, 5 December 2007. <www.sciencedaily.com/releases/2007/12/071204091937.htm>.
American College of Cardiology. (2007, December 5). Simple Two-in-one Test Signals High Risk After A Heart Attack. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2007/12/071204091937.htm
American College of Cardiology. "Simple Two-in-one Test Signals High Risk After A Heart Attack." ScienceDaily. www.sciencedaily.com/releases/2007/12/071204091937.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins